Sub-clinical measurement tools will allow researchers to develop drugs to treat brain diseases before symptoms become visible. Researchers believe that slowing down or even reversing the progression of brain diseases is possible with early treatment.
Quantitative tools will allow physicians to differentiate among diseases, measure and predict progression over time and differentiate patients, enabling early detection and more precise diagnoses. Managed care providers will be able to measure outcomes and identify best practices.
A passive, non-invasive real-time, continuous monitoring solution which measures progression over time will enable pro-active, predictive and personalized patient management. Patients (and their caregivers) will be able to be more involved in the management of their diseases.
Neurodegenerative diseases and disorders represent the largest challenge to the global healthcare system. There are no objective, quantitative tools to measure brain health.
Our Solution: A digital biomarker
NeuraMetrix measures brain health using a digital bio-marker based on consistency of typing cadence
no tests or special equipment
Typing cadence, NOT content
install and forget
Easy to Install
Runs in background
NeuraMetrix TC has applications across a range of users, including researchers, physicians, patients and their caregivers.
Researchers at leading academic institutions around the world are using NeuraMetrix TC in research across a range of diseases and disorders.